Product image of Kyleena (Levonorgestrel) supplied by GNH India

Kyleena

Active Ingredient:
Levonorgestrel
Origin:
EU

Kyleena (Levonorgestrel)

Levonorgestrel, the active ingredient in Kyleena, is a progestin presented as a 52 mg intrauterine system (IUS) for intrauterine use. It provides continuous local hormone release that suppresses ovulation, thickens cervical mucus, and induces endometrial changes, thereby preventing pregnancy for women of reproductive age in the EU market.

GNH India supplies Kyleena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for regulatory‑approved distribution and product support across multiple regions and ensuring compliance with local health authority requirements.

Manufacturer / TM Owner

Bayer Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Kyleena, a levonorgestrel intrauterine system, is indicated for hormonal contraception.
  • Contraception (prevention of pregnancy): provides highly effective reversible birth control for women of reproductive age.
  • Extended‑duration contraception (up to 5 years): maintains contraceptive efficacy for up to five years after insertion.
  • Hormonal birth control for women seeking a non‑daily method: delivers continuous low‑dose levonorgestrel locally, avoiding systemic hormone fluctuations.

How It Works

  • Kyleena releases levonorgestrel directly into the uterine cavity at a low, steady rate. The locally delivered progestin binds to progesterone receptors in the endometrium, suppresses the mid‑cycle luteinising hormone surge, thereby inhibiting ovulation. It also thickens cervical mucus, reducing sperm penetration, and induces endometrial atrophy, creating an environment unsuitable for implantation. These combined actions ensure reliable contraceptive protection without requiring daily dosing.

Side Effects

Kyleena may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Irregular bleeding or spotting
  • Amenorrhea (absence of periods)
  • Pelvic or abdominal pain
  • Cramping after insertion
  • Headache
  • Breast tenderness

Serious or Rare Side Effects

  • Uterine perforation during insertion
  • Pelvic infection (e.g., PID)
  • Ectopic pregnancy if contraception fails
  • Expulsion of the device
  • Allergic reaction to device components

Precautions & Warnings

  • Before using Kyleena, several safety considerations should be reviewed.
  • Pregnancy testing: confirm non‑pregnant status before insertion.
  • Breastfeeding: discuss risks, as levonorgestrel may be excreted in milk.
  • Uterine anomalies: evaluate for abnormalities that may increase insertion complications.
  • History of pelvic infection: assess risk of post‑insertion infection.
  • Smoking: advise cessation, especially in women over 35, due to thrombotic risk.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel released from Kyleena can be affected by other medicines.

Major Interactions (Avoid)

  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) may reduce levonorgestrel efficacy.
  • Concurrent systemic hormonal contraceptives could interfere with local hormone release.
  • Rifampin or griseofulvin may decrease contraceptive effectiveness.

Moderate Interactions (Monitor Closely)

  • Ketoconazole and other strong antifungals may modestly lower hormone levels.
  • St. John’s wort herbal supplement may slightly reduce efficacy.

Frequently Asked Questions

Kyleena is a levonorgestrel intrauterine system designed to provide long‑acting hormonal contraception. It is inserted into the uterus to prevent pregnancy for up to five years by releasing a low dose of levonorgestrel locally.

Levonorgestrel released from Kyleena binds to progesterone receptors in the endometrium, suppresses the mid‑cycle luteinising hormone surge to inhibit ovulation, thickens cervical mucus to block sperm, and induces endometrial atrophy, creating an environment unsuitable for implantation.

The dose of Kyleena is determined by the prescribing clinician. The device contains a fixed 52 mg amount of levonorgestrel that is released continuously; the prescriber decides on insertion and follow‑up based on individual patient needs.

Kyleena is contraindicated in pregnancy (Category X) and should not be inserted in a pregnant woman. For breastfeeding, clinicians evaluate risks because levonorgestrel can be excreted in breast milk, and a risk‑benefit discussion is recommended.

To order Kyleena, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with daily oral progestins or combined pills, Kyleena offers a once‑inserted, low‑maintenance option that delivers hormone locally, reducing systemic exposure. It provides up to five years of protection, whereas many oral methods require daily adherence.

Kyleena should be stored at ambient temperature, below 25 °C, in its original sealed packaging. Protect the device from moisture, direct sunlight and physical damage until the time of insertion.

Kyleena is inserted by a qualified healthcare professional into the uterine cavity through the cervix using a specialized applicator. The procedure is performed in a clinical setting under aseptic conditions, and the device remains in place for up to five years.

Serious risks include uterine perforation during insertion, pelvic infection (including PID), device expulsion, and the rare possibility of ectopic pregnancy if contraception fails. Patients should seek immediate medical attention for severe abdominal pain, fever or abnormal bleeding.

Kyleena is not recommended for women who are currently pregnant, have active pelvic infections, unexplained vaginal bleeding, known uterine anomalies that could impede insertion, or who have a history of breast cancer. Smoking women over 35 should also avoid use due to increased thrombotic risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT